Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Arcturus Therapeutics Holdings Inc. - Special Call Transcript

Oct 29, 2020 / 02:00PM GMT
Release Date Price: $54.98 (+8.42%)
Operator

Hello, and good morning, everyone. Thanks for joining us for B. Riley Research Hosted Liver Disease Therapeutics Day, where we have exciting 5 panel discussions comprising of over 15 companies lined up to review the exciting therapeutics innovation across a number of orphan and large prevalence disease. (Operator Instructions) If you have any questions feel free to send them to our host, Mayank Mamtani, at [email protected].

With that, Mayank, the floor is all yours.

Mayank Mamtani
B. Riley Securities, Inc., Research Division - Research Analyst

Thank you, Kevin. Good morning, everyone. We welcome you to our Virtual Liver Disease Therapeutics Day 2020. I hope everyone is doing well and staying safe. We have an exciting new -- exciting few hours of panel discussions featuring some of the most exciting R&D work happening at a number of innovative biotech companies across a number of liver diseases that we'll speak to.

I'm grateful to management team for making time, Dr. Stephen Harrison in particular for joining the 2 NASH panels. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot